ISHIB 2007 Innovating Vascular Health: Practical Applications to Clinical Practice Critical Challenges in Cardiovascular Disease Program Chairwoman Shawna.
Achieving A1C and Glycemic Targets with Insulin What to Do When Oral Agents Fail New Paradigms, Guidelines, and Evolving Strategies JUAN P. FRIAS, M.D.,
Sensitivity Analysis of Randomized Trials with Missing Data Daniel Scharfstein Department of Biostatistics Johns Hopkins University [email protected].
Frequencies of Resistance-Associated Amino Acid Variants Following Combination Treatment with Boceprevir (BOC) Plus PEGINTRON (PegInterferon Alfa-2b) and.
Epidemiology and Outcomes of IA in the 21st Century: Strengths and Weaknesses of Surveillance Databases Dionissios Neofytos, MD, MPH Transplant & Oncology.
Who should receive early anti-TNF therapy: With what benefits and risks? Ted Denson, MD Cincinnati Childrens Hospital Medical Center University of Cincinnati.
Return to High Altitude Activity After High Altitude Illness Kevin deWeber, MD, FAAFP Director, Primary Care Sports Medicine Fellowship Military Sports.
Dyslipidemia and Cardiovascular Risk Reduction: An Evidence-Based Review Robert M. Guthrie, MD Professor of Emergency Medicine Professor of Internal Medicine.
Inhalers The Perfect technique Vicky Walker Clinical Lead for Respiratory Services Sarah Wilson Respiratory Nurse Specialist.
ANTIMYCOBACTERIAL AGENTS Israa Eltayib. ANTIMYCOBACTERIAL AGENTS The main mycobacterial infections in humans are tuberculosis and leprosy-typically chronic.
Produced in association with McNeil Products Limited – the makers of nicorette ® How we can get the most out of NRT: a review and update on nicotine replacement.
LMC Diabetes Advanced Diabetes Education Workshop Presented by LMC Diabetes and Endocrinology.